# Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

> **NCT00532454** · PHASE2 · TERMINATED · sponsor: **National Cancer Center, Korea** · enrollment: 21 (actual)

## Conditions studied

- Breast Cancer
- Metastatic Disease

## Interventions

- **DRUG:** Tamoxifen

## Key facts

- **NCT ID:** NCT00532454
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2006-06
- **Final completion:** 2007-12
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** planned to design a prospective study
- **Last updated:** 2010-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00532454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00532454, "Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00532454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*